Malignant melanoma and lymphoproliferative malignancy: Is there a shared aetiology?

British Journal of Dermatology

Volumn 143, Issue 1, 2000, Pages 171-173

  McKenna, D B ^a   Doherty, V R ^a   McLaren, K M ^b   Hunter, J A A ^a  

^a Departments of Dermatology   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Chronic lymphatic leukaemia; Immunosuppression; Malignant melanoma; Non Hodgkin's lymphoma; p16 gene; Ultraviolet radiation

Indexed keywords

ALPHA INTERFERON; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; HEREDITY; HUMAN; IMMUNE DEFICIENCY; LYMPH NODE BIOPSY; MALE; MELANOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; ULTRAVIOLET RADIATION;

AGED; DYSPLASTIC NEVUS SYNDROME; FEMALE; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA, NON-HODGKIN; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; SKIN NEOPLASMS; T-LYMPHOCYTES, REGULATORY; ULTRAVIOLET RAYS;

EID: 0033928023     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03610.x     Document Type: Article

References (16)

1. Levi F, Randimbison L. Te VC, La Vecchia C. Non-Hodgkin's lymphomas. chronic lymphocytic leukaemias and skin cancers. ErJ Cancer 1996; 74: 1847-50.
2. Travis LB, Curtis RE, Hankey BF, Fraumeni JF. Second cancers in patients with chronic lymphocytic leukaemia. / Natl Cancer Inst 1992; 84: 1422-7.
3. Riou JFI. Ariyan S. Brandow KR, Fielding LP. The association between melanoma, lymphoma and other primary neoplasms. Arch Snrg 1995; 130: 1056-61.
4. Tucker MA, Misfeldt D, Coleman N et al. Cutaneous malignant melanoma after Hodgkin's disease. Ann Intern Med 1985; 102: 37-41.
5. Greene MH, Young TI. Clark WH. Malignant melanoma in renal transplant recipients. Lancet 1981; i: 1196-9.
6. Spector BD, Filipovich AH. Nonlymphoid cancers as a complication of naturally occurring immunodeficiencies. In: Proceedings of the 71st Annual Meeting of the American Association for Cancer Research. Baltimore, MD: Wavcrly Press, 1980; 151 (Abstr. 603).
7. Vanhaelen PJ, Fisher RI. Increased sensitivity of T cells to regulation by normal suppressor cells persists in long-term survivors with Hodgkin's disease. Am J Med 1982; 72: 385-90.
8. Werkmeister J, McCarthy V, Hersey P. Suppressor cell activity in melanoma patients. 1. Relation to tumour growth and immunoglobulin levels in vivo. Int J Cancer 1981; 28: 1-9.
9. + epidermal macrophage induction, and Langerhans depletion. Proc Natl Acad Sei USA 1992; 89: 8497-501.
10. Bentham G. Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales. Br MedJ 1996; 312: 1128-31.
11. Hall P. Rosendahl I, Mattison A, Einhorn S. Non-Hodgkin's lymphoma and skin malignancies-shared etiology? Int J Cancer 1995: 62: 519-22.
12. Adami J, Frisch M, Yuen J et al. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. Br Med J 1995: 310: 1491-5.
13. Adami J, Grindley G, Nyren 0 et al. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer 1999; 80: 641-5.
14. Kamb A. Gruis NA, Weaver-Feldhaus J et al. A cell cycle regulator potentially involved in genesis of many tumour types. Science 1994:264:436-9.
15. INK4 in sporadic melanoma. / Invest Dermatol 1996; 107: 318-21.
16. Ogawa S, Hirano N, Sato N ft al. Homozygous loss of the cyclindependent kinase 4-inhibitor (pi6) gene in human leukaemias. Blood 1994: 84: 2431-5.